Tag - kidney replacement therapy

Latest ISN Journal Editorial Selections

Kidney International® Improving and Maintaining Quality of Hemodialysis in Areas Conflicted by War: A Call to Action! Alasfar and colleagues discuss the severe impact of the Syrian war on kidney replacement therapy in the region, highlighting logistical challenges and compromised standards of care. They suggest key strategies to help manage kidney care in conflict areas, including understanding...

Enhancing Pediatric Kidney Health in India: The ISN Supports Speakers at Specialized Paediatric Nephrology Meeting

In March, the ISN supported speakers through its Continuing Medical Education Program to attend the "Paediatric Nephro Urocon 2024 - Season 3" meeting in Chennai, India. Seventy delegates participated on the first day of the program, with 125 attending on the second day. The conference brought together a diverse group of professionals, including dialysis technologists,...

Young Nephrologists – Win a Free Registration to the 42nd Vicenza Course: Apply by April 10

The 42nd Vicenza Course AKI-CRRT-ECOS and Critical Care Nephrology 2024 takes place from June 11-13, 2024, at the Fiera di Vicenza Convention Center in Vicenza, Italy. The course will focus on endpoints for new clinical trials and covers various topics in critical care nephrology, including: Acute kidney injury (AKI) in different pathological conditions Sepsis and related mechanisms, including viral, bacterial,...

Latest ISN Journal Editorial Selections

Kidney International® Providing Environmentally Sustainable Nephrology Care: Focus in Low- and Middle-income Countries  This article is part of the series "Green Nephrology: A Series of Mini-Reviews on Minimizing the Environmental Impact of Kidney Health Care," a collaboration between Kidney International® and members of the ISN Emerging Leaders 2022 Program. To help reduce the need for costly and environmentally...

ISN Journal Editorial Selections

Kidney International® A Prospective Controlled, Randomized Clinical Trial of Kidney Transplant Recipients Developed Personalized Tacrolimus Dosing Using Model-based Bayesian Prediction  In this study, a population pharmacokinetic (PPK) model, incorporating factors such as genetics, age, and hematocrit, was developed and validated to optimize tacrolimus (Tac) dosage for kidney transplant recipients. PPK-based dosing was compared with traditional weight-based dosing....